Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Torsade-de-Pointes-Tachykardie

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice. 

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice. 

Berger FA, van der Sijs H, Becker ML, van Gelder T, van den Bemt PMLA. 

BMC Med Inform Decis Mak. 2020;20(1):171. Published 2020 Jul 23. doi:10.1186/s12911-020-01181-3

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice.